Feedback / Questions
Lytenava (bevacizumab-vikg) - Outlook Therap
https://www.globenewswire.com/news-release/2025/08/14/3133447/0/en/Outlook-Therapeutics-Reports-Financial-Results-for-Third-Quarter-Fiscal-Year-2025-and-Provides-Corporate-Update.html
Aug 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next